Correction NoticeCorrection Notice: Technical Aspects of Flow Cytometry-based Measurable Residual Disease Quantification in Acute Myeloid Leukemia: Experience of the European LeukemiaNet MRD Working Party Author Information This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. HemaSphere 6(3):p e703, March 2022. | DOI: 10.1097/HS9.0000000000000703 Open Metrics Since the publication of the article entitled “Technical Aspects of Flow Cytometry-based Measurable Residual Disease Quantification in Acute Myeloid Leukemia: Experience of the European LeukemiaNet MRD Working Party” (HemaSphere. 2022;6(1):e676), the authors have requested a referencing correction. For Table 1, the correct references are 12-16. This has now been adjusted. The changes have been made online: https://journals.lww.com/hemasphere/Fulltext/2022/01000/Technical_Aspects_of_Flow_Cytometry_based.5.aspxCopyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association.View full article text
